Ultrasound Transducer (M1356A), that may have been serviced with the following: Pacific Medical Philips M1356A Ultrasound Board, NFPH9510; Pacific Medical Philips M1356A Ultrasound Bottom Case, NFPH9515; Pacific Medical Philips M1356A Ultrasound Cable Assembly, NFPH9520; Pacific Medical Philips M1356A Ultrasound M1356A Crystal, NFPH9535
Publicado el 19 de febrero de 2020 · Inicio del retiro: 11 de septiembre de 2019
Resumen
FDA registra el retiro Z-1164-2020 de dispositivos médicos de Clase II, publicado el 19 de febrero de 2020 e iniciado el 11 de septiembre de 2019. Empresa responsable: Pacific Medical Group Inc.; Estado: En curso; Cantidad reportada: 1994; Lote: All serial numbers serviced between 12/18/14 and 4/2/19. La Clase II indica posibles consecuencias temporales o médicamente reversibles, o una probabilidad remota de consecuencias graves.
Estado reportado al momento de publicación: Ongoing — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.
Qué peligro representa
Fetal/maternal monitor/monitoring systems serviced or remanufactured using non-OEM equivalent components that have not been appropriately verified or validated. Possible adverse clinical impact: inability to accurately detect and measure fetal heart rate, inability to accurately detect maternal peripheral oxygen saturation, inability to monitor uterine activity to follow contractions, inability to determine temperature, and maternal blood pressure, lack of electrocardiography tracing, patient/clinician burns, and delay in detecting maternal or fetal distress.
Qué hacer
Voluntary: Firm initiated · Letter
Recibe un correo cuando FDA publique un retiro como este
Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.
Detalles del retiro
- Fabricante
- Pacific Medical Group Inc.
- Distribuidor
- Worldwide Distribution - US Nationwide in the states of::NH, NY, MN, PA, FL, AZ, LA, GA, IL, HI, CA, OR, SC, OH, NC, IA, OK, AL, MA, MD, WI, MI, AR, WA, SD, NV, KY, TX, MS, DE, NJ, NE, WV, MT, TN, VA, MO, VT, CO, CT, ME, WY, IN, UT, NM, AK, DC, ID, KS, ND, RI, NH. OUS: BEL, ARE, MEX, CAN, CYM, KOR, ZAF, BHR, ESP, ITA, FRA, VUT, AUS, GBR.
- Lote
- All serial numbers serviced between 12/18/14 and 4/2/19.
- Clasificación de riesgo
- Class II
- Área (FDA)
- device
- País
- United States
Retiros relacionados
- FDALoop-Style Tocotransducer (Nautilus) 2264LAX, that may have been serviced with the following: Pacific Medical19 de febrero de 2020
- FDAToco MP Transducer (M2734B), that may have been serviced with the following: Pacific Medical Philips M2734B19 de febrero de 2020
- FDAButton-Style Ultrasound Transducer (Nautilus), 8-foot Cord 5700HAX, that may have been serviced with the19 de febrero de 2020
- FDASPECIALIST 2 DISTAL FEMORAL CUTTING BLOCK. Part code 966115. The product is a femoral cutting block.19 de febrero de 2020
- FDAImplant Direct, CE 0086, REF: 855710, Legacy 3 Impant, Surface: SBM, Qty:1, Size:5.7mmD x 10mmL, 5.7mmD19 de febrero de 2020
- FDAPacific Medical GE Corometrics Nautilus Ultrasound Transducer w/wing 5700LAX, FFCM526012 de febrero de 2020
Preguntas sobre este retiro
¿Ultrasound Transducer (M1356A), that may have been serviced with the following: Pacific Medical Philips M1356A Ultrasound Board, NFPH9510; Pacific Medical Philips M1356A Ultrasound Bottom Case, NFPH9515; Pacific Medical Philips M1356A Ultrasound Cable Assembly, NFPH9520; Pacific Medical Philips M1356A Ultrasound M1356A Crystal, NFPH9535 fue retirado del mercado?
Sí. FDA publicó el retiro Z-1164-2020 el 19 de febrero de 2020. Peligro reportado: Fetal/maternal monitor/monitoring systems serviced or remanufactured using non-OEM equivalent components that have not been appropriately verified or validated. Possible adverse clinical impact: inability to accurately detect and measure fetal heart rate, inability to accurately detect maternal peripheral oxygen saturation, inability to monitor uterine activity to follow contractions, inability to determine temperature, and maternal blood pressure, lack of electrocardiography tracing, patient/clinician burns, and delay in detecting maternal or fetal distress.
¿Qué debo hacer si tengo este producto?
Voluntary: Firm initiated · Letter